Showing results (1-10 of 657) with videos related to

Sort By:
Pageof 66
Clinical Science (London, England : 1979)|April 11, 2008
Apolipoprotein C-III: understanding an emerging cardiovascular risk factorEsther M M Ooi, P Hugh R Barrett, Dick C Chan, et al.
Metabolism: Clinical and Experimental|April 18, 2019
Fractional turnover of apolipoprotein(a) and apolipoprotein B-100 within plasma lipoprotein(a) particles in statin-treated patients with elevated and normal Lp(a) concentrationLouis Ma, Dick C Chan, Esther M M Ooi, et al.
Atherosclerosis|April 10, 2007
Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndromeEsther M M Ooi, P Hugh R Barrett, Dick C Chan, et al.
Diabetes Care|February 27, 2010
Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss dietDick C Chan, Gerald F Watts, Seng Khee Gan, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2011
Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesityEsther M M Ooi, Gerald F Watts, Dennis L Sprecher, et al.
Journal of Lipid Research|August 30, 2012
Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndromeEsther M M Ooi, Theodore W K Ng, Gerald F Watts, et al.
Current Opinion in Lipidology|February 16, 2010
Genetic determinants of apolipoprotein B-100 kineticsTheodore W K Ng, Esther M M Ooi, Gerald F Watts, et al.
International Journal of Cardiology|August 3, 2013
The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapiesEsther M M Ooi, P Hugh R Barrett, Gerald F Watts
The Journal of Clinical Endocrinology and Metabolism|August 9, 2019
Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) ConcentrationLouis Ma, Dick C Chan, Esther M M Ooi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 21, 2008
Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndromeDick C Chan, Gerald F Watts, Esther M M Ooi, et al.
Pageof 66